Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

182.910
+2.5401.41%
Volume:140.16K
Turnover:25.64M
Market Cap:88.74B
PE:21.01
High:184.340
Open:181.900
Low:181.350
Close:180.370
52wk High:272.649
52wk Low:168.000
Shares:485.15M
Float Shares:483.95M
Volume Ratio:0.96
T/O Rate:0.03%
Dividend:4.26
Dividend Rate:2.33%
EPS(TTM):8.708
EPS(LYR):8.708
ROE:15.37%
ROA:6.63%
PB:3.25
PE(LYR):21.01

Loading ...

Company Profile

Company Name:
CSL LIMITED
Exchange:
ASX
Establishment Date:
1916
Employees:
29904
Office Location:
655 Elizabeth Street,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9389 1434
Introduction:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.